Eli Lilly's stock has been a strong winner over the past few years, powered by its portfolio of glucagon-like peptide-1 ...

This time last year, people were still bickering about whether Novo Nordisk's Wegovy and Eli Lilly & Co.'s Zepbound represented a shortcut to losing weight or a medical breakthrough. But with reams of ...

HFpEF refers to when the heart is unable to pump enough blood to meet the body’s needs. Eli Lilly said the condition is ...

According to GoodRx, compliance rates are high, with only 9% of commercially insured people having full Zepbound coverage and 14% having full Wegovy coverage. This refers to insurance coverage that ...

This proposed rule signals an important shift in the federal approach to obesity management, aligning with the medical ...

Tirzepatide is the active ingredient in Eli ... drugs already? LUPKIN: Yes, though the exact number is hard to pin down. I've ...